Anna Salamero Boix
@asalboix.bsky.social
Neuro-onco-immunology: Postdoc at Dixon Lab @unibas.ch
Contributing to: @openboxscience.bsky.social
Bone marrow donor. First-gen student.
https://orcid.org/my-orcid?orcid=0000-0002-9821-1396
https://www.linkedin.com/in/annasalameroboix/
Contributing to: @openboxscience.bsky.social
Bone marrow donor. First-gen student.
https://orcid.org/my-orcid?orcid=0000-0002-9821-1396
https://www.linkedin.com/in/annasalameroboix/
Reposted by Anna Salamero Boix
First day of the #Microbiome Symposium at #Georg-Speyer-Haus organized by LOEWE-FCI professor Canan Arkan was a great success.
Thanks to all speakers & supporters (Cathrin Schleussner from Schleussner Stiftung and Martin Zörnig, Else-Kröner-Fresenius-Stiftung).
Looking forward to the second day!
Thanks to all speakers & supporters (Cathrin Schleussner from Schleussner Stiftung and Martin Zörnig, Else-Kröner-Fresenius-Stiftung).
Looking forward to the second day!
December 3, 2025 at 8:20 PM
First day of the #Microbiome Symposium at #Georg-Speyer-Haus organized by LOEWE-FCI professor Canan Arkan was a great success.
Thanks to all speakers & supporters (Cathrin Schleussner from Schleussner Stiftung and Martin Zörnig, Else-Kröner-Fresenius-Stiftung).
Looking forward to the second day!
Thanks to all speakers & supporters (Cathrin Schleussner from Schleussner Stiftung and Martin Zörnig, Else-Kröner-Fresenius-Stiftung).
Looking forward to the second day!
Reposted by Anna Salamero Boix
Pre-print alert! And this one really is a must read for anyone that does spectral #flowcytometry. It is a complete, fully-automated spectral unmixing pipeline that reduces error up to 9000-fold.
Want to get a tough sample, like lung, looking like this? Read more!
www.biorxiv.org/content/10.1...
Want to get a tough sample, like lung, looking like this? Read more!
www.biorxiv.org/content/10.1...
October 28, 2025 at 8:06 AM
Pre-print alert! And this one really is a must read for anyone that does spectral #flowcytometry. It is a complete, fully-automated spectral unmixing pipeline that reduces error up to 9000-fold.
Want to get a tough sample, like lung, looking like this? Read more!
www.biorxiv.org/content/10.1...
Want to get a tough sample, like lung, looking like this? Read more!
www.biorxiv.org/content/10.1...
Reposted by Anna Salamero Boix
⚠️ Half of commercial antibodies miss their target!
So how do you pick the right one for your experiment?
Here’s the solution 👉
Antibody characterization data (all tested in KO cells) are now available at:
🔗 onlygoodantibodies.co.uk
Tested by @ycharos.bsky.social & @oga-community.bsky.social
So how do you pick the right one for your experiment?
Here’s the solution 👉
Antibody characterization data (all tested in KO cells) are now available at:
🔗 onlygoodantibodies.co.uk
Tested by @ycharos.bsky.social & @oga-community.bsky.social
OGA - Only Good Antibodies Community
onlygoodantibodies.co.uk
September 29, 2025 at 6:34 PM
⚠️ Half of commercial antibodies miss their target!
So how do you pick the right one for your experiment?
Here’s the solution 👉
Antibody characterization data (all tested in KO cells) are now available at:
🔗 onlygoodantibodies.co.uk
Tested by @ycharos.bsky.social & @oga-community.bsky.social
So how do you pick the right one for your experiment?
Here’s the solution 👉
Antibody characterization data (all tested in KO cells) are now available at:
🔗 onlygoodantibodies.co.uk
Tested by @ycharos.bsky.social & @oga-community.bsky.social
Reposted by Anna Salamero Boix
We are honored to announce that our speaker, Florian Greten, has once again been recognized as one of Clarivate's highly cited researchers for his work on the #tumormicroenvironment of #colorectal #cancer.
#HighlyCited2025
@proloewe.bsky.social @goetheuni.bsky.social
#HighlyCited2025
@proloewe.bsky.social @goetheuni.bsky.social
November 12, 2025 at 7:08 PM
We are honored to announce that our speaker, Florian Greten, has once again been recognized as one of Clarivate's highly cited researchers for his work on the #tumormicroenvironment of #colorectal #cancer.
#HighlyCited2025
@proloewe.bsky.social @goetheuni.bsky.social
#HighlyCited2025
@proloewe.bsky.social @goetheuni.bsky.social
Reposted by Anna Salamero Boix
👏 Congratulations to @melanietichet.bsky.social on being awarded the prestigious #Metastasis Prize by the #Beug Stiftung für Metastasierungsforschung.
@proloewe.bsky.social
@proloewe.bsky.social
November 21, 2025 at 12:36 PM
👏 Congratulations to @melanietichet.bsky.social on being awarded the prestigious #Metastasis Prize by the #Beug Stiftung für Metastasierungsforschung.
@proloewe.bsky.social
@proloewe.bsky.social
Reposted by Anna Salamero Boix
How does the tumor microenvironment change as cancer progresses - & which cells appear, persist, or disappear along the way?
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Study reveals dynamics of breast tumor microenvironment over time | Johanna Joyce posted on the topic | LinkedIn
How does the tumor microenvironment change as cancer progresses — and which cells appear, persist, or disappear along the way?
In this new study, a wonderful collaboration with Jean Hausser and his l...
www.linkedin.com
November 10, 2025 at 3:06 PM
How does the tumor microenvironment change as cancer progresses - & which cells appear, persist, or disappear along the way?
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Reposted by Anna Salamero Boix
💡 A new study in @cp-iscience.bsky.social led by @johannajoyce.bsky.social (@fbm-unil.bsky.social @unil.bsky.social @ludwigcancer.bsky.social) & Jean Hausser (@scilifelab.se @ki.se) tracks how #breast #tumors change over time, cell by cell.
➡️ www.unil.ch/news/1762789...
➡️ www.unil.ch/news/1762789...
Time in the tumor: how cancer and immunity evolve together
By tracking thousands of cells over time, a study in iScience from Johanna Joyce and Jean Hausser exposes how cancer and immunity evolve together and where therapy might strike most effectively. This ...
www.unil.ch
November 11, 2025 at 10:57 AM
💡 A new study in @cp-iscience.bsky.social led by @johannajoyce.bsky.social (@fbm-unil.bsky.social @unil.bsky.social @ludwigcancer.bsky.social) & Jean Hausser (@scilifelab.se @ki.se) tracks how #breast #tumors change over time, cell by cell.
➡️ www.unil.ch/news/1762789...
➡️ www.unil.ch/news/1762789...
Reposted by Anna Salamero Boix
🌍 Interested in hosting an OBS seminar?
Join our 10-minute Host Info Session next Thursday right after the OBS Immunology Seminar!
💡 Learn how to become a host and how you can benefit from the experience.
🕦Thu, Nov 20, 11:30 AM ET
📍 Same Zoom link as the Immunology Seminar
Join our 10-minute Host Info Session next Thursday right after the OBS Immunology Seminar!
💡 Learn how to become a host and how you can benefit from the experience.
🕦Thu, Nov 20, 11:30 AM ET
📍 Same Zoom link as the Immunology Seminar
November 13, 2025 at 7:00 PM
🌍 Interested in hosting an OBS seminar?
Join our 10-minute Host Info Session next Thursday right after the OBS Immunology Seminar!
💡 Learn how to become a host and how you can benefit from the experience.
🕦Thu, Nov 20, 11:30 AM ET
📍 Same Zoom link as the Immunology Seminar
Join our 10-minute Host Info Session next Thursday right after the OBS Immunology Seminar!
💡 Learn how to become a host and how you can benefit from the experience.
🕦Thu, Nov 20, 11:30 AM ET
📍 Same Zoom link as the Immunology Seminar
Reposted by Anna Salamero Boix
Great news: The #LOEWE Center Frankfurt Cancer Institute @goetheuni.bsky.social will continue to receive funding from the state of Hesse! 🎉
12 mio € for two more years – a strong signal for the importance of #translational #cancer #research in Frankfurt.
Thank you Hesse and everyone involved!!
12 mio € for two more years – a strong signal for the importance of #translational #cancer #research in Frankfurt.
Thank you Hesse and everyone involved!!
November 11, 2025 at 7:53 PM
Great news: The #LOEWE Center Frankfurt Cancer Institute @goetheuni.bsky.social will continue to receive funding from the state of Hesse! 🎉
12 mio € for two more years – a strong signal for the importance of #translational #cancer #research in Frankfurt.
Thank you Hesse and everyone involved!!
12 mio € for two more years – a strong signal for the importance of #translational #cancer #research in Frankfurt.
Thank you Hesse and everyone involved!!
Reposted by Anna Salamero Boix
Excited to share our new study in @nataging.nature.com !🎉
www.nature.com/articles/s43...
We show that Urolithin A, a pomegranate-derived gut metabolite, counteracts key signs of immune #aging in a phase I trial!
#immunology #aging @loewe-fci.bsky.social @goetheuni.bsky.social #immunosky
www.nature.com/articles/s43...
We show that Urolithin A, a pomegranate-derived gut metabolite, counteracts key signs of immune #aging in a phase I trial!
#immunology #aging @loewe-fci.bsky.social @goetheuni.bsky.social #immunosky
Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial - Nature Aging
Immune aging fosters multimorbidity and compromises control of infection and cancer. In a phase 1 randomized controlled trial in middle-aged adults, Denk and colleagues administer the mitophagy induce...
www.nature.com
October 31, 2025 at 11:41 AM
Excited to share our new study in @nataging.nature.com !🎉
www.nature.com/articles/s43...
We show that Urolithin A, a pomegranate-derived gut metabolite, counteracts key signs of immune #aging in a phase I trial!
#immunology #aging @loewe-fci.bsky.social @goetheuni.bsky.social #immunosky
www.nature.com/articles/s43...
We show that Urolithin A, a pomegranate-derived gut metabolite, counteracts key signs of immune #aging in a phase I trial!
#immunology #aging @loewe-fci.bsky.social @goetheuni.bsky.social #immunosky
Privileged to hear the views of stakeholders, scientists, diplomats, entrepeneurs, politicians and academics on today's challenges. Thanks to the @ec.europa.eu for the extended invitation to the Science Summit Falling walls as Alumni EUTalentON. Soaking in more inspiration tomorrow!
November 8, 2025 at 8:12 PM
Privileged to hear the views of stakeholders, scientists, diplomats, entrepeneurs, politicians and academics on today's challenges. Thanks to the @ec.europa.eu for the extended invitation to the Science Summit Falling walls as Alumni EUTalentON. Soaking in more inspiration tomorrow!
Reposted by Anna Salamero Boix
"Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer"
New review article from our scientists Franz Rödel, Claus Rödel and Manos Fokas et al in Nature Reviews Clinical Oncology: 👏
Read the full text here ⬇️
rdcu.be/emaSc
New review article from our scientists Franz Rödel, Claus Rödel and Manos Fokas et al in Nature Reviews Clinical Oncology: 👏
Read the full text here ⬇️
rdcu.be/emaSc
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer
Nature Reviews Clinical Oncology - Anal squamous cell carcinoma (ASCC) is a rare malignancy, albeit with an increasing prevalence in most economically developed countries. Despite considerable...
rdcu.be
May 15, 2025 at 1:24 PM
"Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer"
New review article from our scientists Franz Rödel, Claus Rödel and Manos Fokas et al in Nature Reviews Clinical Oncology: 👏
Read the full text here ⬇️
rdcu.be/emaSc
New review article from our scientists Franz Rödel, Claus Rödel and Manos Fokas et al in Nature Reviews Clinical Oncology: 👏
Read the full text here ⬇️
rdcu.be/emaSc
Reposted by Anna Salamero Boix
📍 @loewe-fci.bsky.social, Georg-Speyer-🏠, host "Symposium on #Microbiome" DEC 2025, #Frankfurt am Main. The symposium will explore the evolving role of the microbiome in health, disease & therapeutic innovation. Leading🧑🏼🔬👩🏻🔬experts will present the latest findings on the topic.More👉🏼 lnkd.in/eQmWFMft ⤵️
July 18, 2025 at 8:42 AM
📍 @loewe-fci.bsky.social, Georg-Speyer-🏠, host "Symposium on #Microbiome" DEC 2025, #Frankfurt am Main. The symposium will explore the evolving role of the microbiome in health, disease & therapeutic innovation. Leading🧑🏼🔬👩🏻🔬experts will present the latest findings on the topic.More👉🏼 lnkd.in/eQmWFMft ⤵️
Reposted by Anna Salamero Boix
🔬New article in Molecular Medicine Reports from our mets and glio teams:
„Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma“
Congratulations to @piazeiner.bsky.social & Co-authors!
👉 Read more here:
www.spandidos-publications.com/10.3892/mmr....
„Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma“
Congratulations to @piazeiner.bsky.social & Co-authors!
👉 Read more here:
www.spandidos-publications.com/10.3892/mmr....
October 13, 2025 at 9:56 AM
🔬New article in Molecular Medicine Reports from our mets and glio teams:
„Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma“
Congratulations to @piazeiner.bsky.social & Co-authors!
👉 Read more here:
www.spandidos-publications.com/10.3892/mmr....
„Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma“
Congratulations to @piazeiner.bsky.social & Co-authors!
👉 Read more here:
www.spandidos-publications.com/10.3892/mmr....
Reposted by Anna Salamero Boix
PhD position available in my group in Frankfurt. Explore adaptive immune responses in metastatic colorectal cancer using multi-omics and AIRR profiling. #TRR417 @loewe-fci.bsky.social
georg-speyer-haus.de/karriere/ste...
georg-speyer-haus.de/karriere/ste...
Georg-Speyer-Haus: Doctoral Researcher Positions in Colorectal Cancer Research
georg-speyer-haus.de
September 10, 2025 at 8:29 AM
PhD position available in my group in Frankfurt. Explore adaptive immune responses in metastatic colorectal cancer using multi-omics and AIRR profiling. #TRR417 @loewe-fci.bsky.social
georg-speyer-haus.de/karriere/ste...
georg-speyer-haus.de/karriere/ste...
Reposted by Anna Salamero Boix
Tertiary lymphoid structures in a subset of gliomas that show signs of functional adaptive immune activation and are associated with longer overall patient survival and an immune-permissive tumor microenvironment @cp-immunity.bsky.social
www.cell.com/immunity/ful...
www.cell.com/immunity/ful...
October 21, 2025 at 3:22 PM
Tertiary lymphoid structures in a subset of gliomas that show signs of functional adaptive immune activation and are associated with longer overall patient survival and an immune-permissive tumor microenvironment @cp-immunity.bsky.social
www.cell.com/immunity/ful...
www.cell.com/immunity/ful...
Reposted by Anna Salamero Boix
Online now: Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures
Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures
Gliomas respond poorly to therapy and are considered immunologically “cold” tumors. Cakmak et al. identify tertiary lymphoid structures (TLSs) in a subset of gliomas that show signs of functional adaptive immune activation and are associated with longer overall patient survival and an immune-permissive tumor microenvironment. Such TLSs may represent a key determinant of glioma immune landscape, with clinical relevance.
dlvr.it
October 21, 2025 at 2:48 PM
Online now: Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures
Reposted by Anna Salamero Boix
Two powerful strategies in one treatment: Researchers at the University of Basel and University Hospital Basel have demonstrated that a newly developed fusion protein can both block the “do not attack” signal used by cancer cells and selectively activate tumor-fighting immune cells.
Stronger together: a new fusion protein boosts cancer immunotherapy
A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel have demonstrated that this fusi...
www.unibas.ch
September 18, 2025 at 7:19 AM
Two powerful strategies in one treatment: Researchers at the University of Basel and University Hospital Basel have demonstrated that a newly developed fusion protein can both block the “do not attack” signal used by cancer cells and selectively activate tumor-fighting immune cells.
Reposted by Anna Salamero Boix
Thrilled to see our @openboxscience.bsky.social comment published in
@natneuro.nature.com
🌍📖 nature.com/articles/s41...
PDF: openboxscience.com/wp-content/u...
Free, global webinar platforms can break barriers in science & support careers everywhere.
Join US!
@natneuro.nature.com
🌍📖 nature.com/articles/s41...
PDF: openboxscience.com/wp-content/u...
Free, global webinar platforms can break barriers in science & support careers everywhere.
Join US!
Globally accessible platforms for the exchange of research findings and career development - Nature Neuroscience
Researchers’ access to scientific research findings remains inequitable owing to financial and geographical barriers, highlighting the need for more sustainable and inclusive modes of communication to...
nature.com
September 22, 2025 at 8:12 PM
Thrilled to see our @openboxscience.bsky.social comment published in
@natneuro.nature.com
🌍📖 nature.com/articles/s41...
PDF: openboxscience.com/wp-content/u...
Free, global webinar platforms can break barriers in science & support careers everywhere.
Join US!
@natneuro.nature.com
🌍📖 nature.com/articles/s41...
PDF: openboxscience.com/wp-content/u...
Free, global webinar platforms can break barriers in science & support careers everywhere.
Join US!
September 22, 2025 at 8:04 PM
Thank you to
@natneuro.nature.com
for allowing us,
@openboxscience.bsky.social
, to discuss about the importance of scientific exchange and about platforms to make it happen.
nature.com/articles/s41...
@natneuro.nature.com
for allowing us,
@openboxscience.bsky.social
, to discuss about the importance of scientific exchange and about platforms to make it happen.
nature.com/articles/s41...
Globally accessible platforms for the exchange of research findings and career development - Nature Neuroscience
Researchers’ access to scientific research findings remains inequitable owing to financial and geographical barriers, highlighting the need for more sustainable and inclusive modes of communication to...
nature.com
September 21, 2025 at 7:30 PM
Thank you to
@natneuro.nature.com
for allowing us,
@openboxscience.bsky.social
, to discuss about the importance of scientific exchange and about platforms to make it happen.
nature.com/articles/s41...
@natneuro.nature.com
for allowing us,
@openboxscience.bsky.social
, to discuss about the importance of scientific exchange and about platforms to make it happen.
nature.com/articles/s41...
Reposted by Anna Salamero Boix
OBS Seminar: Neuroimmunology
👩🔬 Sara Trabanelli University of Geneva
"Neural anticipation of virtual infection triggers an immune response"
🗓️ Thu 25th September7:00 AM PDT 10:00 AM EDT 2:00 PM GMT 4:00 PM CEST
👇 Registration:
us02web.zoom.us/meeting/regi...
👩🔬 Sara Trabanelli University of Geneva
"Neural anticipation of virtual infection triggers an immune response"
🗓️ Thu 25th September7:00 AM PDT 10:00 AM EDT 2:00 PM GMT 4:00 PM CEST
👇 Registration:
us02web.zoom.us/meeting/regi...
Welcome! You are invited to join a meeting: OBS Immunology Seminar . After registering, you will receive a confirmation email about joining the meeting.
Help Wanted: CD4⁺ T Cells as Architects and Rescuers of CD8⁺ T Cell Responses Verena Van Der Heide, (Icahn School of Medicine at Mount Sinai ) Prolonged but finite antigen presentation promotes reversible...
us02web.zoom.us
September 15, 2025 at 1:02 PM
OBS Seminar: Neuroimmunology
👩🔬 Sara Trabanelli University of Geneva
"Neural anticipation of virtual infection triggers an immune response"
🗓️ Thu 25th September7:00 AM PDT 10:00 AM EDT 2:00 PM GMT 4:00 PM CEST
👇 Registration:
us02web.zoom.us/meeting/regi...
👩🔬 Sara Trabanelli University of Geneva
"Neural anticipation of virtual infection triggers an immune response"
🗓️ Thu 25th September7:00 AM PDT 10:00 AM EDT 2:00 PM GMT 4:00 PM CEST
👇 Registration:
us02web.zoom.us/meeting/regi...
Reposted by Anna Salamero Boix
In a recent study, scientists have found a clear presence of immune cells, particularly T cells, in the cranial bones of patients with glioblastoma before surgery. Anna Salamero Boix writes.
oncobites.blog/2025/08/27/s...
oncobites.blog/2025/08/27/s...
Skull bone marrow as a source for immune cells in glioma
Reading time: 5 minutes Anna Salamero Boix The tumor microenvironment has emerged as a potential therapeutic target in cancer therapy. Within the tumor microenvironment, tumor-associated immune cel…
oncobites.blog
August 27, 2025 at 1:29 PM
In a recent study, scientists have found a clear presence of immune cells, particularly T cells, in the cranial bones of patients with glioblastoma before surgery. Anna Salamero Boix writes.
oncobites.blog/2025/08/27/s...
oncobites.blog/2025/08/27/s...
Reposted by Anna Salamero Boix
🧬2nd Semester 2025 lineup is here!
Join us for a new round of cutting-edge immunology seminars from top researchers around the world!
Mark your calendar & share!
For more info: linktr.ee/globalimmuno...
Join us for a new round of cutting-edge immunology seminars from top researchers around the world!
Mark your calendar & share!
For more info: linktr.ee/globalimmuno...
August 5, 2025 at 8:35 AM
🧬2nd Semester 2025 lineup is here!
Join us for a new round of cutting-edge immunology seminars from top researchers around the world!
Mark your calendar & share!
For more info: linktr.ee/globalimmuno...
Join us for a new round of cutting-edge immunology seminars from top researchers around the world!
Mark your calendar & share!
For more info: linktr.ee/globalimmuno...